Matic G B, Ullrich H, Barlage S, Rothe G, Schmitz G
Institut für Klinische Chemie/Zentrallabor, Klinikum der Universität Regensburg, Deutschland.
Beitr Infusionsther Transfusionsmed. 1997;34:139-43.
Despite many published studies no parameter could be identified yet to acceptably and individually predict collection results in stem cell apheresis. We analyzed leukocyte counts and processed blood volume, absolute and relative CD34+ cell counts, and overall collection efficiency in 120 patients with hematological and solid malignancies (354 leukaphereses using the Cobe Spectra cell separator, a median of 3 per patient, span 1-9). Stem cells were mobilized into peripheral blood by conventional chemotherapy followed by daily doses of G-CSF. CD34+ progenitor cell counts were monitored through multiparametric flow cytometry. Blood and collection flows varied in the range of 45-90 ml/min and 0.7-1.5 ml/min, respectively. CD34+ progenitor cells were enriched 38-fold in the apheresis product as compared to peripheral blood at a processed blood volume lower than one total blood volume. Efficiency continuously declined, on to a 25-fold concentration at a processed blood volume above the 3-fold total blood volume. Total collection efficiency, calculated from the absolute content of CD34+ progenitor cells in peripheral blood and apheresis concentrate (a parameter for progenitor cell mobilization during the apheresis), reached a plateau at a processed blood volume above the 3-fold total blood volume. However, variation among individual patients was high. The concentration rate of CD34+ cells at a leukocyte count below 5,000/microliter averaged 50 and declined continuously to 8 at leukocyte counts between 45,000 and 50,000/microliter. To summarize, in 70% of patients with leukocyte counts below 5,000/microliter and CD34+ progenitor cell counts above 10,000/ml, more than 1.5 x 10(6) progenitors per kg body weight could be collected in a single leukapheresis. According to the presented data, the variation in overall collection efficiency is mainly due to: 1) varying mobilization of progenitors during the apheresis procedures itself and 2) dependence on peripheral leukocyte counts.
尽管已有许多研究发表,但尚未确定任何参数能够以可接受的方式单独预测干细胞单采的采集结果。我们分析了120例血液系统和实体恶性肿瘤患者的白细胞计数、处理血量、绝对和相对CD34+细胞计数以及总体采集效率(使用Cobe Spectra细胞分离仪进行了354次白细胞单采,每位患者平均3次,范围为1 - 9次)。通过常规化疗,随后每日给予粒细胞集落刺激因子(G-CSF),将干细胞动员至外周血中。通过多参数流式细胞术监测CD34+祖细胞计数。血液流速和采集流速分别在45 - 90 ml/分钟和0.7 - 1.5 ml/分钟范围内变化。在处理血量低于一个全血量时,采集产物中的CD34+祖细胞比外周血富集了38倍。当处理血量高于3倍全血量时,效率持续下降,降至25倍富集浓度。根据外周血和单采浓缩物中CD34+祖细胞的绝对含量计算的总体采集效率(单采过程中祖细胞动员的一个参数)在处理血量高于3倍全血量时达到平台期。然而,个体患者之间的差异很大。白细胞计数低于5000/微升时,CD34+细胞的富集率平均为50,当白细胞计数在45000至50000/微升之间时,富集率持续下降至8。总之,在70%白细胞计数低于5000/微升且CD34+祖细胞计数高于10000/毫升的患者中,单次白细胞单采可采集到每千克体重超过1.5×10⁶个祖细胞。根据所呈现的数据,总体采集效率的差异主要归因于:1)单采过程中祖细胞动员的差异以及2)对外周白细胞计数的依赖。